dalteparin has been researched along with Lung Diseases, Interstitial in 4 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Lung Diseases, Interstitial: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, W | 1 |
| Zhang, N | 1 |
| Guo, W | 1 |
| Gao, F | 1 |
| Peters, BJ | 1 |
| Hofer, M | 1 |
| Daniels, CE | 1 |
| Winters, JL | 1 |
| Laxer, U | 1 |
| Lossos, IS | 1 |
| Gillis, S | 1 |
| Or, R | 1 |
| Christensen, TG | 1 |
| Goldstein, RH | 1 |
| Breuer, R | 1 |
| Watanabe, K | 1 |
| Tajima, S | 1 |
| Tanaka, J | 1 |
| Moriyama, H | 1 |
| Nakayama, H | 1 |
| Terada, M | 1 |
| Takada, T | 1 |
| Suzuki, E | 1 |
| Narita, I | 1 |
4 other studies available for dalteparin and Lung Diseases, Interstitial
| Article | Year |
|---|---|
Combined pharmacotherapy for osteonecrosis of the femoral head after severe acute respiratory syndrome and interstitial pneumonia: two and a half to fourteen year follow-up.
Topics: Adult; Alendronate; Alprostadil; Bone Density Conservation Agents; Drug Therapy, Combination; Enoxap | 2018 |
Effect of plasma exchange on antifactor Xa activity of enoxaparin and serum levetiracetam levels.
Topics: Enoxaparin; Factor Xa Inhibitors; Female; Humans; Levetiracetam; Lung Diseases, Interstitial; Middle | 2018 |
The effect of enoxaparin on bleomycin-induced lung injury in mice.
Topics: Animals; Anticoagulants; Bleomycin; Bronchoalveolar Lavage Fluid; Cell Count; Enoxaparin; Factor Xa; | 1999 |
[Effects of anticoagulant therapy for rapidly progressive interstitial pneumonias].
Topics: Anticoagulants; Dalteparin; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Lung Disease | 2011 |